Poniewierski, M. S., Crawford, J., Dale, D. C., Culakova, E., Kuderer, N. M., Wolff, D. A., & Lyman, G. H. (2008). Reduced chemotherapy dose intensity in patients with ovarian cancer: Results from a prospective nationwide study. In Journal of Clinical Oncology (Vol. 26, pp. 16508–16508). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2008.26.15_suppl.16508

Poniewierski, M. S., J. Crawford, D. C. Dale, E. Culakova, N. M. Kuderer, D. A. Wolff, and G. H. Lyman. “Reduced chemotherapy dose intensity in patients with ovarian cancer: Results from a prospective nationwide study.” In Journal of Clinical Oncology, 26:16508–16508. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.16508.

Poniewierski MS, Crawford J, Dale DC, Culakova E, Kuderer NM, Wolff DA, et al. Reduced chemotherapy dose intensity in patients with ovarian cancer: Results from a prospective nationwide study. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 16508–16508.

Poniewierski, M. S., et al. “Reduced chemotherapy dose intensity in patients with ovarian cancer: Results from a prospective nationwide study.” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2008, pp. 16508–16508. Crossref, doi:10.1200/jco.2008.26.15_suppl.16508.

Poniewierski MS, Crawford J, Dale DC, Culakova E, Kuderer NM, Wolff DA, Lyman GH. Reduced chemotherapy dose intensity in patients with ovarian cancer: Results from a prospective nationwide study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 16508–16508.